Plaque Psoriasis Treatment

The ‘Global Psoriasis Plaque Treatment Market Size, Trends, Price, Growth, Report and Forecast 2023-2031′ by Expert Market Research provides a comprehensive outlook of the global plaque psoriasis treatment market, evaluating the market based on its segments such as diagnosis methods, therapy type, route of administration, drug type, population type, end user, distribution channel, and major regions.

Global Plaque Psoriasis Treatment Market Size, Share, Growth, Industry Report, Key Player, Major Segments, and Forecast

The key highlights of the report include:

Market Overview (2016-2031)

• Forecast CAGR (2023-2031): 3%

The growth of global plaque psoriasis treatment market is driven by factors such as increasing prevalence of plaque psoriasis, growing awareness about the disease, and advances in treatment options. The market growth is further fuelled by the availability of various treatment options, such as topical treatments, phototherapy, and systemic medications, along with the development of biologics targeting specific pathways in the immune system.

Get a Free Sample Report with Table of Contents –

However, the high cost of certain treatments, especially biologics, and the lack of access to effective treatments in some regions may hinder the growth of the market.

Nevertheless, the rising prevalence of plaque psoriasis and the development of new and improved treatment options are expected to propel the global plaque psoriasis treatments market during the forecast period.

Plaque Psoriasis Treatment Industry Definition and Major Segments

Psoriasis refers to a skin condition which leads to red, inflamed, raised, and itchy skin on different parts of the body. The condition has various types and plaque psoriasis is one of the most common types, affecting more than 8 million Americans every year. About 90% of psoriasis patients suffer from plaque psoriasis, making it the most prevalent type of the condition. The replacement of old skin cells with new ones results in the production of plaques over the skin. The increased prevalence of the condition is providing significant impetus to the growth of the plaque psoriasis treatment market.

Read Full Report with Table of Contents –

Market Breakup by Diagnosis

• Blood Tests
• Skin Prick Test
• Patch Test
• Biopsy
• Others

Market Breakup by Treatment Type

• Biologics Drugs
• Systemic Drugs
• Phototherapy
• Topical Drugs

Market Breakup by Therapy Type

• Monotherapy
• Combination therapy

Market Breakup by Route of Administration

• Oral
• Injectable
• Topical

Market Breakup by Drug Type

• Over The Counter
• Prescription

Market Breakup by Population Type

• Adult’s
• Geriatrics

Market Breakup by End User

• Hospitals
• Speciality Clinics
• Homecare Settings
• Others

Market Breakup by Distribution Channels

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Other

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Plaque Psoriasis Treatment Market Trends

Recent trends in the plaque psoriasis treatment market include the approval of new biologics and small molecule therapies, increased adoption of personalized medicine approaches, and the use of digital health solutions for patient monitoring and treatment adherence. There is also a growing interest in the development of novel drug delivery systems, such as microneedles and transdermal patches, to enhance the efficacy and safety of treatments.

Key Market Players

The major players in the plaque psoriasis treatment market report include

• AbbVie Inc.,
• Amgen Inc.,
• Eli Lilly and Company,
• Johnson & Johnson,
• Novartis AG,
• Pfizer Inc.,
• Sun Pharmaceutical Industries Ltd.,
• UCB S.A., and
• Valeant Pharmaceuticals International, Inc.

The report covers the market shares, capacities, plant turnarounds, expansions, investments, and mergers and acquisitions, among other latest developments of these market players.

About Us:

Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.

EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.

Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.

Media Contact:

Company Name: Claight Corporation
Contact Person: Alex Steven, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA

Leave a Reply

Your email address will not be published.